{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:10:10Z","timestamp":1790885410815,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260471"],"award-info":[{"award-number":["82260471"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund","award":["SKL\u2011HIDCA\u20112024\u2011SG7"],"award-info":[{"award-number":["SKL\u2011HIDCA\u20112024\u2011SG7"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50108-x","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:26:28Z","timestamp":1777292788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer-associated fibroblasts -derived Tenascin-C activates the Hippo\/TAZ pathway to suppress ferroptosis and confer cisplatin resistance in esophageal cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Xueling","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiheriban","family":"Aikebai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiyere","family":"Abulimiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliyaer","family":"Nuerrula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidiye","family":"Tiliwalidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayinur","family":"Eli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"50108_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"50108_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s12885-022-09712-z","volume":"22","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis. BMC Cancer. 22, 616. https:\/\/doi.org\/10.1186\/s12885-022-09712-z (2022).","journal-title":"BMC Cancer"},{"key":"50108_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","volume":"41","author":"G Caligiuri","year":"2023","unstructured":"Caligiuri, G. & Tuveson, D. A. Activated fibroblasts in cancer: Perspectives and challenges. Cancer Cell. 41, 434\u2013449. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.015 (2023).","journal-title":"Cancer Cell."},{"key":"50108_CR4","doi-asserted-by":"publisher","unstructured":"Chen, C. Y. et al. Cancer-Associated-Fibroblast-Mediated Paracrine and Autocrine SDF-1\/CXCR4 Signaling Promotes Stemness and Aggressiveness of Colorectal Cancers. Cells 13 https:\/\/doi.org\/10.3390\/cells13161334 (2024).","DOI":"10.3390\/cells13161334"},{"key":"50108_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol. Cancer. 19, 43. https:\/\/doi.org\/10.1186\/s12943-020-01168-8 (2020).","journal-title":"Mol. Cancer"},{"key":"50108_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41419-019-1581-6","volume":"10","author":"X Long","year":"2019","unstructured":"Long, X. et al. Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1\/ER\u03b2\/Bcl-2 signalling. Cell. Death Dis. 10, 375. https:\/\/doi.org\/10.1038\/s41419-019-1581-6 (2019).","journal-title":"Cell. Death Dis."},{"key":"50108_CR7","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/cas.13998","volume":"110","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells. Cancer Sci. 110, 1609\u20131620. https:\/\/doi.org\/10.1111\/cas.13998 (2019).","journal-title":"Cancer Sci."},{"key":"50108_CR8","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2217\/fon-2020-0095","volume":"16","author":"F Zhang","year":"2020","unstructured":"Zhang, F. et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12\/CXCR4 axis. Future Oncol. 16, 2619\u20132633. https:\/\/doi.org\/10.2217\/fon-2020-0095 (2020).","journal-title":"Future Oncol."},{"key":"50108_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-021-02669-8","volume":"24","author":"S Li","year":"2022","unstructured":"Li, S. & Huang, Y. Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy. Clin. Transl Oncol. 24, 1\u201312. https:\/\/doi.org\/10.1007\/s12094-021-02669-8 (2022).","journal-title":"Clin. Transl Oncol."},{"key":"50108_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo, J. et al. Ferroptosis: A Novel Anti-tumor Action for Cisplatin. Cancer Res. Treat. 50, 445\u2013460. https:\/\/doi.org\/10.4143\/crt.2016.572 (2018).","journal-title":"Cancer Res. Treat."},{"key":"50108_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","volume":"483","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett. 483, 127\u2013136. https:\/\/doi.org\/10.1016\/j.canlet.2020.02.015 (2020).","journal-title":"Cancer Lett."},{"key":"50108_CR12","doi-asserted-by":"publisher","unstructured":"Zhao, Y., Sheldon, M., Sun, Y. & Ma, L. New Insights into YAP\/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer. Cancers (Basel). 15. https:\/\/doi.org\/10.3390\/cancers15235497 (2023).","DOI":"10.3390\/cancers15235497"},{"key":"50108_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/cs20201474","volume":"136","author":"R Cunningham","year":"2022","unstructured":"Cunningham, R. & Hansen, C. G. The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer. Clin. Sci. (Lond). 136, 197\u2013222. https:\/\/doi.org\/10.1042\/cs20201474 (2022).","journal-title":"Clin. Sci. (Lond)"},{"key":"50108_CR14","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1158\/0008-5472.Can-14-2346","volume":"75","author":"E Jachetti","year":"2015","unstructured":"Jachetti, E. et al. Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation. Cancer Res. 75, 2095\u20132108. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-2346 (2015).","journal-title":"Cancer Res."},{"key":"50108_CR15","doi-asserted-by":"publisher","unstructured":"Wickman, E. et al. IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors. J. Immunother Cancer. 12 https:\/\/doi.org\/10.1136\/jitc-2024-009743 (2024).","DOI":"10.1136\/jitc-2024-009743"},{"key":"50108_CR16","first-page":"5641","volume":"13","author":"S Furuhashi","year":"2023","unstructured":"Furuhashi, S. et al. Tenascin C in pancreatic cancer-associated fibroblasts enhances epithelial mesenchymal transition and is associated with resistance to immune checkpoint inhibitor. Am. J. Cancer Res. 13, 5641\u20135655 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"50108_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bbrc.2017.03.021","volume":"486","author":"WD Ni","year":"2017","unstructured":"Ni, W. D. et al. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer. Biochem. Biophys. Res. Commun. 486, 607\u2013612. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.021 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"50108_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12929-024-01078-7","volume":"31","author":"CH Hsieh","year":"2024","unstructured":"Hsieh, C. H. et al. Decreased plasma gelsolin fosters a fibrotic tumor microenvironment and promotes chemoradiotherapy resistance in esophageal squamous cell carcinoma. J. Biomed. Sci. 31, 90. https:\/\/doi.org\/10.1186\/s12929-024-01078-7 (2024).","journal-title":"J. Biomed. Sci."},{"key":"50108_CR19","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/ijc.31953","volume":"144","author":"H Kashima","year":"2019","unstructured":"Kashima, H. et al. Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma. Int. J. Cancer. 144, 828\u2013840. https:\/\/doi.org\/10.1002\/ijc.31953 (2019).","journal-title":"Int. J. Cancer"},{"key":"50108_CR20","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 49, D545\u2013d551. https:\/\/doi.org\/10.1093\/nar\/gkaa970 (2021).","journal-title":"Nucleic Acids Res."},{"key":"50108_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/jjco\/hyw082","volume":"46","author":"Y Sasaki","year":"2016","unstructured":"Sasaki, Y. & Kato, K. Chemoradiotherapy for esophageal squamous cell cancer. Jpn J. Clin. Oncol. 46, 805\u2013810. https:\/\/doi.org\/10.1093\/jjco\/hyw082 (2016).","journal-title":"Jpn J. Clin. Oncol."},{"key":"50108_CR22","doi-asserted-by":"publisher","first-page":"1428920","DOI":"10.3389\/fimmu.2024.1428920","volume":"15","author":"Y Cao","year":"2024","unstructured":"Cao, Y. et al. Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation. Front. Immunol. 15, 1428920. https:\/\/doi.org\/10.3389\/fimmu.2024.1428920 (2024).","journal-title":"Front. Immunol."},{"key":"50108_CR23","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/0008-5472.Can-24-1816","volume":"85","author":"J Zhan","year":"2025","unstructured":"Zhan, J. et al. Targeting LTBP2 Derived from Cancer-Associated Fibroblasts Sensitizes Esophageal Squamous Cell Carcinoma to Chemotherapy. Cancer Res. 85, 2412\u20132428. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-1816 (2025).","journal-title":"Cancer Res."},{"key":"50108_CR24","doi-asserted-by":"publisher","first-page":"e2307914120","DOI":"10.1073\/pnas.2307914120","volume":"120","author":"B Liu","year":"2023","unstructured":"Liu, B. et al. Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma. Proc. Natl. Acad. Sci. U S A. 120, e2307914120. https:\/\/doi.org\/10.1073\/pnas.2307914120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"50108_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12967-025-06246-3","volume":"23","author":"K Zhang","year":"2025","unstructured":"Zhang, K., Guo, L., Li, X., Hu, Y. & Luo, N. Cancer-associated fibroblasts promote doxorubicin resistance in triple-negative breast cancer through enhancing ZFP64 histone lactylation to regulate ferroptosis. J. Transl Med. 23, 247. https:\/\/doi.org\/10.1186\/s12967-025-06246-3 (2025).","journal-title":"J. Transl Med."},{"key":"50108_CR26","doi-asserted-by":"publisher","first-page":"100960","DOI":"10.1016\/j.drup.2023.100960","volume":"68","author":"R Qi","year":"2023","unstructured":"Qi, R. et al. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist. Updat. 68, 100960. https:\/\/doi.org\/10.1016\/j.drup.2023.100960 (2023).","journal-title":"Drug Resist. Updat"},{"key":"50108_CR27","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41388-024-03057-6","volume":"43","author":"J Zhao","year":"2024","unstructured":"Zhao, J. et al. Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer. Oncogene 43, 2104\u20132114. https:\/\/doi.org\/10.1038\/s41388-024-03057-6 (2024).","journal-title":"Oncogene"},{"key":"50108_CR28","doi-asserted-by":"publisher","first-page":"e0116683","DOI":"10.1371\/journal.pone.0116683","volume":"10","author":"F Liu","year":"2015","unstructured":"Liu, F. et al. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis. PLoS One. 10, e0116683. https:\/\/doi.org\/10.1371\/journal.pone.0116683 (2015).","journal-title":"PLoS One"},{"key":"50108_CR29","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2741\/4682","volume":"23","author":"P Busek","year":"2018","unstructured":"Busek, P., Mateu, R., Zubal, M., Kotackova, L. & Sedo, A. Targeting fibroblast activation protein in cancer - Prospects and caveats. Front. Biosci. (Landmark Ed. 23, 1933\u20131968. https:\/\/doi.org\/10.2741\/4682 (2018).","journal-title":"Front. Biosci. (Landmark Ed."},{"key":"50108_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/2159-8290.Cd-18-0193","volume":"9","author":"A Kaur","year":"2019","unstructured":"Kaur, A. et al. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov. 9, 64\u201381. https:\/\/doi.org\/10.1158\/2159-8290.Cd-18-0193 (2019).","journal-title":"Cancer Discov"},{"key":"50108_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41419-018-0458-4","volume":"9","author":"Y Cheng","year":"2018","unstructured":"Cheng, Y. et al. Cancer-associated fibroblasts induce PDL1\u2009+\u2009neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. Cell. Death Dis. 9, 422. https:\/\/doi.org\/10.1038\/s41419-018-0458-4 (2018).","journal-title":"Cell. Death Dis."},{"key":"50108_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41374-018-0185-6","volume":"99","author":"N Higashino","year":"2019","unstructured":"Higashino, N. et al. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma. Lab. Invest. 99, 777\u2013792. https:\/\/doi.org\/10.1038\/s41374-018-0185-6 (2019).","journal-title":"Lab. Invest."},{"key":"50108_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrd4161","volume":"13","author":"R Johnson","year":"2014","unstructured":"Johnson, R. & Halder, G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 13, 63\u201379. https:\/\/doi.org\/10.1038\/nrd4161 (2014).","journal-title":"Nat. Rev. Drug Discov"},{"key":"50108_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s43018-022-00473-z","volume":"4","author":"S Piccolo","year":"2023","unstructured":"Piccolo, S., Panciera, T., Contessotto, P. & Cordenonsi, M. YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat. Cancer. 4, 9\u201326. https:\/\/doi.org\/10.1038\/s43018-022-00473-z (2023).","journal-title":"Nat. Cancer"},{"key":"50108_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.tibs.2020.08.012","volume":"46","author":"F Reggiani","year":"2021","unstructured":"Reggiani, F., Gobbi, G., Ciarrocchi, A. & Sancisi, V. YAP and TAZ Are Not Identical Twins. Trends Biochem. Sci. 46, 154\u2013168. https:\/\/doi.org\/10.1016\/j.tibs.2020.08.012 (2021).","journal-title":"Trends Biochem. Sci."},{"key":"50108_CR36","doi-asserted-by":"publisher","first-page":"188756","DOI":"10.1016\/j.bbcan.2022.188756","volume":"1877","author":"F Lo Sardo","year":"2022","unstructured":"Lo Sardo, F., Canu, V., Maugeri-Sacc\u00e0, M., Strano, S. & Blandino, G. Y. A. P. Monocorial and bicorial transcriptional co-activators in human cancers. Biochim. Biophys. Acta Rev. Cancer. 1877, 188756. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188756 (2022).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"50108_CR37","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","volume":"28","author":"WH Yang","year":"2019","unstructured":"Yang, W. H. et al. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. Cell. Rep. 28, 2501\u20132508e2504. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.107 (2019).","journal-title":"Cell. Rep."},{"key":"50108_CR38","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/s41416-023-02182-5","volume":"128","author":"J Luo","year":"2023","unstructured":"Luo, J. et al. The oncogenic roles and clinical implications of YAP\/TAZ in breast cancer. Br. J. Cancer. 128, 1611\u20131624. https:\/\/doi.org\/10.1038\/s41416-023-02182-5 (2023).","journal-title":"Br. J. Cancer"},{"key":"50108_CR39","doi-asserted-by":"publisher","first-page":"1699375","DOI":"10.1080\/23723556.2019.1699375","volume":"7","author":"WH Yang","year":"2020","unstructured":"Yang, W. H. & Chi, J. T. Hippo pathway effectors YAP\/TAZ as novel determinants of ferroptosis. Mol. Cell. Oncol. 7, 1699375. https:\/\/doi.org\/10.1080\/23723556.2019.1699375 (2020).","journal-title":"Mol. Cell. Oncol."},{"key":"50108_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1158\/1541-7786.Mcr-19-0691","volume":"18","author":"WH Yang","year":"2020","unstructured":"Yang, W. H. et al. A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer. Mol. Cancer Res. 18, 79\u201390. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-0691 (2020).","journal-title":"Mol. Cancer Res."},{"key":"50108_CR41","doi-asserted-by":"publisher","first-page":"108577","DOI":"10.1016\/j.pharmthera.2023.108577","volume":"253","author":"W Chen","year":"2024","unstructured":"Chen, W. et al. Clinical advances in TNC delivery vectors and their conjugate agents. Pharmacol. Ther. 253, 108577. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108577 (2024).","journal-title":"Pharmacol. Ther."},{"key":"50108_CR42","doi-asserted-by":"publisher","unstructured":"Katoh, D. et al. Binding of \u03b1v\u03b21 and \u03b1v\u03b26 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells. Oncogenesis 2 (e65). https:\/\/doi.org\/10.1038\/oncsis.2013.27 (2013).","DOI":"10.1038\/oncsis.2013.27"},{"key":"50108_CR43","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajpath.2010.10.015","volume":"178","author":"K Nagaharu","year":"2011","unstructured":"Nagaharu, K. et al. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am. J. Pathol. 178, 754\u2013763. https:\/\/doi.org\/10.1016\/j.ajpath.2010.10.015 (2011).","journal-title":"Am. J. Pathol."},{"key":"50108_CR44","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1097\/cm9.0000000000002533","volume":"136","author":"K Ding","year":"2023","unstructured":"Ding, K. et al. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism. Chin. Med. J. (Engl). 136, 2521\u20132537. https:\/\/doi.org\/10.1097\/cm9.0000000000002533 (2023).","journal-title":"Chin. Med. J. (Engl)"},{"key":"50108_CR45","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. U S A. 113, E4966\u20134975. https:\/\/doi.org\/10.1073\/pnas.1603244113 (2016).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"50108_CR46","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.tips.2024.05.006","volume":"45","author":"J Liu","year":"2024","unstructured":"Liu, J., Tang, D. & Kang, R. Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges. Trends Pharmacol. Sci. 45, 666\u2013670. https:\/\/doi.org\/10.1016\/j.tips.2024.05.006 (2024).","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50108-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50108-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50108-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:55:16Z","timestamp":1782168916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50108-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50108"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50108-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval and consent to participate Human tissue studies were approved (approval nos. K202507-07, respectively) and monitored by the Ethics Committee of the First Afffliated Hospital of Xinjiang Medical University (Urumqi, China). Human tissue studies were conducted in accordance with the 1964 Helsinki Declaration and its later amendments of comparable ethical standards. Informed consent was obtained from all patients or their legal guardian, and the data were analysed anonymously throughout the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Ethical approval and participation consent were obtained for all animal experiments under the First Afffliated Hospital of Xinjiang Medical University. (approval nos. 20241210\u201123, respectively)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}],"article-number":"19422"}}